Facilitating Impella® Weaning and Explant Decision Making Dr. Rajan Patel discusses how SmartAssist technology has helped him make decisions about explanting and weaning in his high-risk PCI cases. Dr. Patel is an interventional cardiologist at Ochsner Medical Center. Dr. Patel describes a subset of protected PCI patients, including those with acute coronary syndromes or very low … Continue reading “SmartAssist in Protected PCI”
State of the Art Approach for Optimizing Patients Prior to TAVR Dr. Siddharth Wayangankar discusses his protected PCI strategy for managing patients with severe aortic stenosis and low EF with multivessel disease, specifically difficult to stent distal left main lesions. “The bottom line is that these patients need complete revascularization before considering TAVR,” he tells … Continue reading “Challenging Impella-supported Protected PCI Cases”
Dr. Alexander Truesdell, Interventional Cardiologist at Inova Heart and Vascular Institute discusses his editorial, the War on Shock, published in the Journal of Invasive Cardiology. The editorial compares his experience as a military physician with his experience as a cardiologist treating cardiogenic shock. Watch the video to learn which systems of care Dr. Truesdell suggests … Continue reading “Identifying Cardiogenic Shock Early with a Heart Team Approach”
- This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
- Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
- In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
- The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Case Review: High-Risk PCI Case Using Impella® Heart Pump Support on an Unprotected Left Main Coronary Artery
Dr. David Lasorda presents a high-risk PCI case using Impella® heart pump support to address an unprotected left main coronary artery with orbital atherectomy. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. IM2-051-17
Dr. Behnam Tehrani of Inova Heart and Vascular Institute explains an After Action Review (AAR) program to evaluate the shock program at his hospital. Watch the video to learn how to initiate an AAR program. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. NPS-097-17
Dr. Raja Hatem has created more than 100 PowerPoint presentations. He explains how to make an impactful PowerPoint for presenting case reviews. IM2-052-17
Abiomed’s Sheila Gebel and Maggie Flynn explain the role and importance of a Protected PCI Coordinator and the use of algorithms and protocols. NPS-050-17
Michael Hacala, Detroit Cardiogenic Shock (DCSI) Coordinator at Henry Ford Hospital. Tune in to hear updates about the program, and learn how to participate. Partnering hospital systems participating in DCSI use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients … Continue reading “Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala”
Dr. Perwaiz Meraj of Northwell Health discusses a new study demonstrating potential survival with Impella 2.5® heart pump insertion pre-PCI in heart attacks involving the left main coronary artery. IM2-049-17 v3